Drug Class
GHRH peptides
Growth hormone-releasing hormone analog
About the GHRH class
6 peptides on PeptideHelper.org are tagged with this class.
Class assignments are editorial; some peptides span multiple mechanism classes. Most peptides catalogued are not FDA-approved for human use.
Peptides in this class (6)
- CJC-1295 , GHRH analog (no-DAC or DAC forms) · Anecdotal + Phase 2 (DAC) · Compounding Restricted · 57 citations
- Tesamorelin , GHRH analog (FDA-approved) · FDA-Approved · Prescription · 165 citations
- Sermorelin , GHRH analog · Discontinued (FDA approval 1990; US withdrawal 2008) · Compounding Restricted · 247 citations
- CJC-1295 + Ipamorelin , GHRH analog + selective GHRP blend (GH-secretagogue stack) · Anecdotal + Animal Studies · Compounding Restricted · 6 citations
- Tesamorelin + Ipamorelin , FDA-approved GHRH analog (Tesamorelin) + selective GHRP (Ipamorelin) blend · FDA-Approved (component) · Compounding Restricted · 2 citations
- Hulk Stack , GH + IGF stack: GHRH analog + selective GHRP + long-acting IGF-1 analog · Anecdotal · Compounding Restricted
Frequently asked questions
What is a GHRH peptide?
Growth hormone-releasing hormone analog
Which peptides are in the GHRH class?
6 peptides catalogued on PeptideHelper.org are tagged GHRH: CJC-1295, Tesamorelin, Sermorelin, CJC-1295 + Ipamorelin, Tesamorelin + Ipamorelin, Hulk Stack.
Are any GHRH peptides FDA-approved?
2 GHRH peptides are FDA-approved on PeptideHelper.org's catalog: Tesamorelin, Tesamorelin + Ipamorelin.
Browse the full PeptideHelper.org catalog with filters for evidence tier, regulatory status, and goal area.
Loading interactive view…